- Jazz and Azur combine to form new Irish specialty pharma
- J&J agrees to acquire Alza for stock
- All that Jazz: biggest biotech venture round ever
- Jazz Pharmaceuticals acquires Orphan Medical
- Jazz licenses US rights to Solvay's Luvox formulations
- Initial public offering for Jazz Pharmaceuticals nets $100.4mm
- Longitude Capital affiliates fund Jazz Pharma with $7mm
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.